INNV logo

INNVInnovAge Holding Corp

$8.86
$0.29
(3.17%)
Pre-Market
Updated: 04:00 AM EDT·Prev Close $9.15
EarningsSep 8
Mkt Cap$1.13B
Vol1.00
News
all
press releases
InnovAge (NASDAQ:INNV) Issues Earnings Results
InnovAge (NASDAQ:INNV - Get Free Report) announced its quarterly earnings data on Tuesday. The company reported ($0.22) EPS for the quarter, missing the consensus estimate of $0.06 by ($0.28). InnovAge had a net margin of 0.71% and a return on equity of 2.60...
MarketBeat
News Placeholder
More News
News Placeholder
InnovAge Q3 Earnings Call Highlights
InnovAge (NASDAQ:INNV) reported fiscal third-quarter 2026 results that management said reflected stronger operating execution and the benefits of investments made to strengthen its platform. The...
MarketBeat
News Placeholder
Full Transcript: InnovAge Holding Q3 2026 Earnings Call
read more...
Benzinga
News Placeholder
InnovAge Holding Corp. (INNV) Reports Q3 Loss, Beats Revenue Estimates
InnovAge (INNV) delivered earnings and revenue surprises of -488.01% and +7.46%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
News Placeholder
Can Strong Growth Aid INNV's Q3 Earnings Amid Margin Seasonality?
InnovAge heads into fiscal Q3 earnings with strong growth momentum and margin gains, but seasonal cost pressures and fading Medicaid tailwinds may temper near-term upside.
Zacks
News Placeholder
InnovAge Holding Corp. (NASDAQ:INNV) Sees Significant Growth in Short Interest
InnovAge Holding Corp. (NASDAQ:INNV - Get Free Report) was the target of a large growth in short interest during the month of April. As of April 15th, there was short interest totaling 701,414...
MarketBeat
News Placeholder
InnovAge (INNV) to Release Quarterly Earnings on Tuesday
InnovAge (NASDAQ:INNV) will be releasing its Q3 2026 earnings after the market closes on Tuesday, May 5. (View Earnings Report at...
MarketBeat
News Placeholder
Organon (OGN) Soars 30.9%: Is Further Upside Left in the Stock?
Organon (OGN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
Zacks
News Placeholder
HCA Healthcare Q1 Earnings Miss Estimates on Rising Expenses
HCA's Q1 EPS misses estimates as rising expenses and weaker surgeries weigh despite modest revenue growth and gains in ER visits.
Zacks
News Placeholder
ELV Beats Q1 Earnings Estimates on Rising Net Investment Income
Elevance Health beats Q1 EPS estimates as net investment income jumps 29.7%, offsetting membership decline and higher expenses.
Zacks
<
1
2
...
>

Advertisement|Remove ads.